BENDROFLUMETHIAZIDE; NADOLOL - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bendroflumethiazide; nadolol and what is the scope of patent protection?
Bendroflumethiazide; nadolol
is the generic ingredient in two branded drugs marketed by King Pharms Llc, Impax Labs, and Natco Pharma, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for BENDROFLUMETHIAZIDE; NADOLOL
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| DailyMed Link: | BENDROFLUMETHIAZIDE; NADOLOL at DailyMed |
Recent Clinical Trials for BENDROFLUMETHIAZIDE; NADOLOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mylan Pharmaceuticals | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for BENDROFLUMETHIAZIDE; NADOLOL
US Patents and Regulatory Information for BENDROFLUMETHIAZIDE; NADOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 077833-002 | Mar 30, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 078688-002 | Feb 15, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-002 | May 25, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 077833-001 | Mar 30, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-001 | May 25, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BENDROFLUMETHIAZIDE; NADOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-001 | May 25, 1983 | ⤷ Sign Up | ⤷ Sign Up |
| King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-002 | May 25, 1983 | ⤷ Sign Up | ⤷ Sign Up |
| King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-002 | May 25, 1983 | ⤷ Sign Up | ⤷ Sign Up |
| King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-001 | May 25, 1983 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
